We analyzed the induction of tumor-reactive CD8+ cytotoxic T cells (CTLs) in a cohort of AML patients (n = 23) undergoing combined DNR and ARA-C chemotherapy. The gene discussed is CD8A; the disease is acute myeloid leukemia.